Reaching People, Changing Lives

At Aurinia Pharmaceuticals, we’re developing innovative products for patients living with debilitating diseases.

How We’re Helping Patients

Latest News

January 22, 2019 • 12:00am EST

Aurinia Announces Voclosporin Ophthalmic Solution Demonstrates Statistically Superior Efficacy Versus Restasis® in a Phase 2 Head-to-Head Study for the Treatment of Dry Eye Syndrome

Read Press Release View All News

January 21, 2019 • 12:00am EST

Aurinia to Hold Conference Call and Webcast to Discuss Results of Phase 2 Head-to-Head Study of Voclosporin Ophthalmic Solution versus Restasis® for the Treatment of Dry Eye Syndrome

Read Press Release View All News

December 19, 2018 • 12:00am EST

Aurinia to Present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco

Read Press Release View All News

Email Alerts

Stay informed and receive company updates straight to your inbox

Sign Up Today